AstraZeneca partners with BT for �25m global net

BT has announced a £25m, five-year deal to become the global network partner for pharmaceutical firm AstraZeneca. The agreement sees BT providing a single delivery platform, with the existing BT-managed global MPLS network in EMEA and Asia Pacific extended to 33 new sites in the US and Latin America.

BT has announced a £25m, five-year deal to become the global network partner for pharmaceutical firm AstraZeneca. The new agreement will see BT providing a single delivery platform, with the existing BT-managed global MPLS network in EMEA and Asia Pacific extended to 33 new sites in the US and Latin America.

The new contract covers a total of 170 managed connections at 131 AstraZeneca sites in 60 countries. AstraZeneca's network carries 6Tb of data each day. The relationship between the two organisations is not new: BT has provided network services for AstraZeneca since 2003.

The expanded network will give all AstraZeneca personnel access to real-time information wherever and whenever they need it, and provide a foundation for the convergence of voice, video, and other multimedia applications across a single global platform, said Richard Williams, AstraZeneca's global CIO.

"AstraZeneca is a telling example of how global businesses are increasingly reliant upon permanent connectivity between a high number of sites around the world," added Laurie Bowen, managing director Commercial & Brands, BT Global Services.

www.astrazeneca.com

www.bt.com

Image: The AstraZeneca/BT contract covers a 170 managed connections at 131 AstraZeneca sites in 60 countries ̵1; including the pharmaceutical giant's office in Osaka, Japan.

What do you think about the issues raised in this news story? Share your views at the IT discussion forum.

More IT industry news from the IET

Recent articles

Info Message

Our sites use cookies to support some functionality, and to collect anonymous user data.

Learn more about IET cookies and how to control them

Close